BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

SubscribeLog In More Log in via InstitutionLog in via OpenAthens Log in using your username and password Basket Search More Advanced search Latest contentCurrent issueArchiveAuthorsAboutPodcasts Advanced search CloseMore Main menu Latest contentCurrent issueArchiveAuthorsAboutPodcasts SubscribeLog in More Log in via InstitutionLog in via OpenAthens Log in using your username and password BMJ Journals You are hereHomeOnline FirstBCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial Email alerts Article Text Article menu Article TextArticle infoCitation ToolsShareRapid ResponsesArticle metricsAlerts PDF Systemic lupus erythematosus BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial Weijia Wang1, Shanzhi He1, Wenli Zhang2, Hongyu Zhang2, Vincent M DeStefano3, Masayuki Wada3, Kevin Pinz3, Greg Deener3, Darshi Shah3, Nabil Hagag3, Min Wang1, Ming Hong1, Ronghao Zeng1, Ting Lan1, Yu Ma4, Fugui Li...